For the quarter ending 2025-12-31, ARWR made $264,033K in revenue. $30,811K in net income. Net profit margin of 11.67%.
| Income Statement | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
| Revenue | 264,033 | 129,486 | 27,767 | 542,709 |
| Research and development | 177,203 | 151,790 | 162,368 | 133,102 |
| General and administrative | 46,021 | 32,295 | 30,949 | 28,405 |
| Total operating expenses | 223,224 | 188,139 | 193,317 | 161,507 |
| Operating income (loss) | 40,809 | -58,653 | -165,550 | 381,202 |
| Interest income | 9,690 | 8,328 | 11,019 | 9,615 |
| Interest expense | 22,505 | 21,670 | 24,382 | 21,639 |
| Other, net | 277 | 2,499 | -176 | 438 |
| Total other expense | -12,538 | -10,844 | -13,539 | -11,586 |
| Income (loss) before income tax expense and noncontrolling interest | 28,271 | -69,497 | -179,089 | 369,616 |
| Income tax expense | 29 | 10,052 | -437 | 1,753 |
| Net income (loss) including noncontrolling interest | 28,242 | -79,548 | -178,652 | 367,863 |
| Net loss attributable to noncontrolling interest, net of tax | -2,569 | 18,869 | -3,411 | -2,582 |
| Net income (loss) attributable to arrowhead pharmaceuticals, inc | 30,811 | -98,417 | -175,241 | 370,445 |
| Basic (in dollars per share) | 0.22 | -0.765 | -1.26 | 2.78 |
| Basic (in shares) | 137,039,000 | -69,322,000 | 139,039,000 | 133,363,000 |
| Diluted (in dollars per share) | 0.22 | -0.75 | -1.26 | 2.75 |
| Diluted (in shares) | 140,706,000 | -69,882,500 | 139,039,000 | 134,484,000 |
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)